Today, kaléo announced that ALLERJECT® epinephrine auto-injectors will be widely available in pharmacies across Canada starting May 19, 2020.
With ALLERJECT, Canadians now have access to a different option for an epinephrine auto-injector. Read kaléo’s statement and our FAQs below.
Read kaléo’s statement for details on the ALLERJECT launch and other product details.
We have worked hard to help make this happen on behalf of the food allergy community
We have been strongly advocating over the last two years to ensure there is always affordable access to life-saving medication by having a minimum of two epinephrine auto-injector suppliers in Canada long-term. We worked continuously with the Government of Canada, provincial governments, pharmaceutical companies, and other key stakeholders to advocate on the behalf of those impacted, pushing for Canada to no longer be vulnerable to shortages and other device constraints that comes with being in a single-source market.
Together, with the food allergy community’s commitment and support, we have made significant change for all Canadians impacted by food allergy.
There is no better way to commemorate Food Allergy Awareness Month than by announcing this huge advocacy win!